Class IITerminatedD-1649-2019
Drug recall · August 14, 2019
DIMERCAPTO-PROPANESULFONIC 5% recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DIMERCAPTO-PROPANESULFONIC 5% (DMPS)( (PFV) INJ SOL, 5 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0904-05
- Lots / codes
All lots within expiry
- Quantity
- N/A
- Company
- RXQ Compounding LLC, Athens, OH
- Distribution
- Nationwide USA
- Initiated
- June 19, 2019 · Voluntary: Firm initiated
- Classified
- August 8, 2019
- Reported
- August 14, 2019
- Ended
- September 16, 2022
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IITerminatedAug 14, 2019Ascorbic Acid 500 MG/MLRXQ Compounding LLC · D-1634-2019Class IITerminatedAug 14, 2019Ascorbic Acid 400 MG/MLRXQ Compounding LLC · D-1635-2019Class IITerminatedAug 14, 2019Ascorbic Acid 500 MG/MLRXQ Compounding LLC · D-1636-2019Class IITerminatedAug 14, 2019Avastin, 25MG/ML SyringeRXQ Compounding LLC · D-1637-2019Class IITerminatedAug 14, 2019BUFFERED LIDOCAINE 1%+EPI 1:100RXQ Compounding LLC · D-1638-2019Class IITerminatedAug 14, 2019BUFFERED LIDOCAINE HCL 1% INJECTION SOLUTIONRXQ Compounding LLC · D-1639-2019Class IITerminatedAug 14, 2019BUFFERED LIDOCAINE HCL 1% INJECTION SOLRXQ Compounding LLC · D-1640-2019Class IITerminatedAug 14, 2019CALCIUM CHLORIDE 100MG/MLRXQ Compounding LLC · D-1641-2019Class IITerminatedAug 14, 2019CALCIUM GLUCONATE 5% INJECTION SOLUTIONRXQ Compounding LLC · D-1642-2019Class IITerminatedAug 14, 2019Copper 0.4MG/MLRXQ Compounding LLC · D-1643-2019Class IITerminatedAug 14, 2019CYANCOBALAMIN 1200MCG/ML MDV INJECTIONRXQ Compounding LLC · D-1644-2019Class IITerminatedAug 14, 2019DEXPANTHENOL 250MG/MLRXQ Compounding LLC · D-1645-2019
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.